Overview: GALT Enzyme Activity TestIntroduction: The GALT Enzyme Activity Test measures GALT enzyme activity to diagnose galactosemia, causing liver issues or developmental delays, helping guide dietary restrictions. Affecting 1 in 60,000 newborns, galactosemia poses diagnostic challenges due to early onset. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses enzymatic assay for high accuracy, supporting biochemistry screening. This test is vital for diagnosis, dietary planning, and improving outcomes in pediatrics.
Other Names: GALT Activity Test, Galactosemia Enzyme Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: GALT testing began in the 1960s with research by Kalckar, who linked enzyme deficiency to galactosemia. Enzymatic assay advancements in the 1990s by Roche improved detection, surpassing earlier qualitative methods.
Purpose: Measures GALT enzyme activity to diagnose galactosemia, guides galactose-free diet, and evaluates patients with developmental delays, aiming to prevent complications.
Test Parameters: GALT enzyme activity
Pretest Condition: No special preparation required. Collect whole blood or red blood cells. Report history of metabolic issues.
Specimen: Whole Blood (EDTA, 2-5 mL), Red Blood Cells (EDTA, 2-5 mL); 4 mL whole blood in Na Heparin tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not recommended
Medical History: Document developmental delay or liver issues. Include current medications or dietary habits.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., cirrhosis), and sample collection risks.
Procedural Considerations: Uses enzymatic assay to measure GALT activity, requiring labs with spectrophotometers. Results available in 5-7 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample hemolysis or delay can affect results. Medications may not affect results but require correlation.
Clinical Significance: Low activity confirms galactosemia, guiding therapy. Early dietary changes might prevent damage, while untreated cases lead to death. Normal levels may require genetic tests.
Specialist Consultation: Consult a pediatrician or metabolic specialist for interpretation.
Additional Supporting Tests: Galactose levels, genetic panel, or liver function test to confirm diagnosis.
Test Limitations: Specific to GALT enzyme; correlation with symptoms needed. False negatives possible with atypical cases.
References: ACMG Guidelines, 2023; Journal of Biological Chemistry, Kalckar HM, 2022.
